Vaccine Contract Manufacturing Market: Global Market Size, Forecast, Insights, and Competitive Landscape

The Global Vaccine Contract Manufacturing market is expected to grow at a CAGR of around 10% during 2022-2028. This report on Global Vaccine Contract Manufacturing market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the Global Vaccine Contract Manufacturing market by segmenting the market based on type, application, distribution channel, end user and region. Also, detailed profiles of companies operating in the Vaccine Contract Manufacturing market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision. 

Market Drivers 

• Increasing awareness about the benefits of vaccination in developing nations.
• Rising demands of generic medication.
• Increasing demands of cell and gene therapy

Market Challenges   

• Outsourcing by well-established vaccine makers is limited.

Historical & Forecast Period

Base Year: 2021

Historical Period: 2017-2020

Forecast Period: 2022-2028

Market by Process Type

• Upstream
• Downstream 

Market by Product Type 

• Single Vaccine
  • Ebola Virus
  • Influenza Virus
  • Smallpox
  • Chickenpox
  • Tetanus
  • Polio
  • Tuberculosis
  • Others
• Combination Vaccine

Market by Vaccine Type 

• Subunit Vaccines
• Live Attenuated Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Recombinant Vector Vaccines
• Toxoid Vaccines
• Synthetic Vaccines

Market by Scale of Operation

• Commercial
• Pre-Clinical
• Clinical

Market by Service 

• Bulk Product
• Fill Finish

Market by Region

• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • Turkey
  • Iran
  • United Arab Emirates
  • Rest of Middle East & Africa

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Vaccine Contract Manufacturing Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Vaccine Contract Manufacturing Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Vaccine Contract Manufacturing Market by Process Type
5.1. Introduction
5.2. Upstream
5.3. Downstream
6. Global Vaccine Contract Manufacturing Market by Product Type
6.1. Introduction
6.2. Single Vaccine
6.2.1. Ebola Virus
6.2.2. Influenza Virus
6.2.3. Smallpox
6.2.4. Chickenpox
6.2.5. Tetanus
6.2.6. Polio
6.2.7. Tuberculosis
6.2.8. Others
6.3. Combination Vaccine
7. Global Vaccine Contract Manufacturing Market by Vaccine Type
7.1. Introduction
7.2. Subunit Vaccines
7.3. Live Attenuated Vaccines
7.4. Conjugate Vaccines
7.5. Inactivated Vaccines
7.6. Recombinant Vector Vaccines
7.7. Toxoid Vaccines
7.8. Synthetic Vaccines
8. Global Vaccine Contract Manufacturing Market by Scale of Operation
8.1. Introduction
8.2. Commercial
8.3. Pre-Clinical
8.4. Clinical
9. Global Vaccine Contract Manufacturing Market by Service
9.1. Introduction
9.2. Bulk Product
9.3. Fill Finish
10. Global Vaccine Contract Manufacturing Market by Region
10.1. Introduction
10.2. Europe
10.2.1. Germany
10.2.2. United Kingdom
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Russia
10.2.7. Netherlands
10.2.8. Rest of the Europe
10.3. North America
10.3.1. United States
10.3.2. Canada
10.4. Asia Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. South Korea
10.4.5. Australia
10.4.6. Indonesia
10.4.7. Rest of the Asia Pacific
10.5. Latin America
10.5.1. Mexico
10.5.2. Brazil
10.5.3. Argentina
10.5.4. Rest of Latin America
10.6. Middle East & Africa
10.6.1. Saudi Arabia
10.6.2. Turkey
10.6.3. Iran
10.6.4. United Arab Emirates
10.6.5. Rest of Middle East & Africa
11. SWOT Analysis
12. Porter’s Five Forces
13. Market Value Chain Analysis
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Company Profiles
14.2.1. Albany Molecular Research Inc
14.2.2. Merck KGaA
14.2.3. Ajinomoto Co. Inc
14.2.4. Boehringer Ingelheim
14.2.5. Catalent Inc
14.2.6. Cobra Biologics Limited (Charles River Laboratories International Inc.)
14.2.7. Cytovance Biologics Inc. (Hepalink USA Inc.)
14.2.8. Fujifilm Holdings Corporation
14.2.9. GlaxoSmithKline
14.2.10. ICON plc
14.2.11. IDT Biologika GmbH
14.2.12. Lonza Group AG
14.2.13. Merck KGaA
14.2.14. Pfizer
14.2.15. Pharmaceutical Product Development LLC
14.2.16. PRA Health Sciences Inc.
14.2.17. Recipharm
14.2.18. Serum Institute of India
*List is not exhaustive

List of Figures

Figure 1: Global Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 2: Global Vaccine Contract Manufacturing Market by Process Type, 2021
Figure 3: Global Vaccine Contract Manufacturing Market by Product Type, 2021
Figure 4: Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021
Figure 5: Global Vaccine Contract Manufacturing Market by Scale of Operation, 2021
Figure 6: Global Vaccine Contract Manufacturing Market by Service, 2021
Figure 7: Global Vaccine Contract Manufacturing Market by Region, 2021
Figure 8: Global Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 9: Global Vaccine Contract Manufacturing Market by Process Type (in %), 2021 & 2028
Figure 10: Global Upstream Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 11: Global Upstream Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 12: Global Downstream Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 13: Global Downstream Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 14: Global Vaccine Contract Manufacturing Market by Product Type (in %), 2021 & 2028
Figure 15: Global Single Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 16: Global Single Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 17: Ebola Virus Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 18: Influenza Virus Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 19: Smallpox Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 20: Chickenpox Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 21: Tetanus Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 22: Polio Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 23: Tuberculosis Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 24: Others Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 25: Global Combination Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 26: Global Combination Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 27: Global Vaccine Contract Manufacturing Market by Vaccine Type (in %), 2021 & 2028
Figure 28: Global Subunit Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 29: Global Subunit Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 30: Global Live Attenuated Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 31: Global Live Attenuated Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 32: Global Conjugate Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 33: Global Conjugate Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 34: Global Inactivated Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 35: Global Inactivated Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 36: Global Recombinant Vector Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 37: Global Recombinant Vector Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 38: Global Toxoid Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 39: Global Toxoid Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 40: Global Synthetic Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 41: Global Synthetic Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 42: Global Vaccine Contract Manufacturing Market by Scale of Operation (in %), 2021 & 2028
Figure 43: Global Commercial Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 44: Global Commercial Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 45: Global Pre-Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 46: Global Pre-Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 47: Global Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 48: Global Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 49: Global Vaccine Contract Manufacturing Market by Service (in %), 2021 & 2028
Figure 50: Global Bulk Product Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 51: Global Bulk Product Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 52: Global Fill Finish Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 53: Global Fill Finish Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 54: Global Vaccine Contract Manufacturing Market by Region (in %), 2021 & 2028
Figure 55: Europe Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 56: Europe Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 57: Europe Vaccine Contract Manufacturing Market by Country (in %), 2021 & 2028
Figure 58: Germany Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 59: United Kingdom Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 60: France Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 61: Italy Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 62: Spain Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 63: Russia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 64: Netherlands Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 65: North America Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 66: North America Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 67: North America Vaccine Contract Manufacturing Market by Country (in %), 2021 & 2028
Figure 68: United States Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 69: Canada Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 70: Asia Pacific Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 71: Asia Pacific Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 72: Asia Pacific Vaccine Contract Manufacturing Market by Country (in %), 2021 & 2028
Figure 73: China Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 74: Japan Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 75: India Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 76: South Korea Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 77: Australia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 78: Indonesia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 79: Latin America Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 80: Latin America Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 81: Latin America Vaccine Contract Manufacturing Market by Country (in %), 2021 & 2028
Figure 82: Mexico Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 83: Brazil Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 84: Argentina Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 85: Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2017-2021
Figure 86: Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2022-2028
Figure 87: Middle East & Africa Vaccine Contract Manufacturing Market by Country (in %), 2021 & 2028
Figure 88: Saudi Arabia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 89: Turkey Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 90: Iran Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 91: UAE Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 92: Rest of Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2017-2028
Figure 93: Market Value Chain

List of Tables

Table 1: Global Vaccine Contract Manufacturing Market Portraiture
Table 2: Global Vaccine Contract Manufacturing Market by Process Type (in US$ Million), 2021 & 2028
Table 3: Global Vaccine Contract Manufacturing Market by Product Type (in US$ Million), 2021 & 2028
Table 4: Global Single Vaccine Contract Manufacturing Market by Product Type (in US$ Million), 2021 & 2028
Table 5: Global Vaccine Contract Manufacturing Market by Vaccine Type (in US$ Million), 2021 & 2028
Table 6: Global Vaccine Contract Manufacturing Market by Vaccine Type (in US$ Million), 2021 & 2028
Table 7: Global Plastic Vaccine Contract Manufacturing Market by Scale of Operation (in US$ Million), 2021 & 2028
Table 8: Global Vaccine Contract Manufacturing Market by Sevice (in US$ Million), 2021 & 2028
Table 9: Global Vaccine Contract Manufacturing Market by Region (in US$ Million), 2021 & 2028
Table 10: List of Key Players